Announcements Trials
Browse Landscape

Phase

Phase 2 40Phase 1 36Phase NA 19Phase 1/2 19Phase 3 12Phase 4 5Phase EARLY_PHASE1 3Phase 2/3 3

Status

Not yet recruiting 2Recruiting 1Enrolling by invitation 1Completed 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 11Other hematologic neoplasm 8Genitourinary 8Gastrointestinal 7Plasma cell 6Dermatologic 5Head & Neck 4Myeloid 3Sarcoma 2Lymphoid 2Gynecologic 2Classical hematology 2Thoracic 1Other 1CNS 1

Conditions

Melanoma 2Squamous Cell Carcinoma of Head and Neck 1Skin Substitutes 1Skin Neoplasms 1Neoplasm Metastasis 1Lung Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Carcinoma, Basal Cell 1

Interventions

Immune Checkpoint Inhibitors 2oxycodone-acetaminophen 1Therapeutics 1Specimen Handling 1Skin, Artificial 1HhAntag691 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 4 × Dermatologic × 30 days × Clear all
NCT07405086 2026-05-22

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

OHSU Knight Cancer Institute

Phase 4 Recruiting
160 enrolled
DermatologicGastrointestinalGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Lung Neoplasms, Melanoma, Neoplasm Metastasis

NCT03610022 2026-05-19

OPTIVISMO-1

University Hospital, Bordeaux

Phase 4 Completed
27 enrolled
Dermatologic

Carcinoma, Basal Cell

NCT07587749 2026-05-14

Skin Subs vs Secondary Intention

Baylor Research Institute

Phase 4 Not yet recruiting
50 enrolled
Dermatologic

Skin Substitutes

NCT07575230 2026-05-11

Suzetrigine vs Norco-postoperative Mohs Pain

Baylor Research Institute

Phase 4 Enrolling by invitation
75 enrolled
Dermatologic

Skin Neoplasms

NCT07574047 2026-05-07

MELCHRONO: A Prospective Randomized Study Investigating Chrono-immunotherapy for Advanced Melanoma.

Swiss Cancer Institute

Phase 4 Not yet recruiting
108 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡